I have great pleasure writing this opening to the special edition of the Australian Journal of Chemistry dedicated to nanomedicine. Many of you would be aware that I have been a part of the Centre for Advanced Macromolecular Design (CAMD) for 10 years. It was a privilege when the Executive of UNSW asked me to establish and co-direct a new research centre in nanomedicine -The Australian Centre for NanoMedicine (ACN) (Fig. 1) .
ACN has two key aims: first and foremost is as a research centre dedicated to finding solutions to provide a better way of life for those in our population afflicted with hard-to-treat diseases; and second to work with a diversity of stakeholder groups to communicate research findings and be an Australian hub for nanomedicine discussion and commentary.
Both of these aims were central to ACN hosting the 2nd International NanoMedicine Conference from 14 to 16 July 2011. As we spent three glorious Sydney winter days overlooking Coogee Beach as whales undertook their northern migration before us, 200 attendees representing over 25 invited speakers, 30 posters and 10 nationalities discussed their research under the headings of targeted delivery, diagnostics, imaging, sensing, nanosafety, regenerative medicine, and a special session on translational medicine.
For the second consecutive year, it was ACN's pleasure to bring together the top minds in a discipline that crosses borders incorporating medicine, chemistry, and engineering and truly represents the adage of 'bench to bedside', but just as importantly 'bedside to bench'. Day 2's conference program concluded with yet more social activities. First off was the presentation and support of 30 posters in the foyer of the Crowne Plaza Hotel. Following the poster display, ACN and CAMD PhD students arranged for attending PhD students to visit the local Coogee Beach nightlife (Fig. 3) . I cannot overemphasise the need for these social activities to build cross-disciplinary and cross-institutional relations. But it was not until the final night of the conference that the awards and winners of the poster prizes were announced. NSW's Chief Scientist and Chief Engineer, Professor Mary O'Kane, was the guest of honour at the conference gala dinner and tasked with presenting prizes to the best oral and poster presentations. What I am most pleased about is that we now scan through newspapers and news programs where virtually every day we hear or read about advances in the treatment of diseases, especially those diseases that may have meant a life sentence just a few years back. Today, our cutting edge research has enormous potential to influence future clinical care, especially for patients with cancer, diabetes, cardiovascular diseases, multiple sclerosis, Alzheimer's and Parkinson's disease, and inflammatory and/or infectious diseases. What is most exciting is that often the researchers are Australian researchers working in some of the world's best research institutions and facilities. There is no doubt that Australia's work in medical research, including nanomedicine, is world class. 
